1. 987 Emipediology and Morbidity of Late Preterm Neonates in Correlation with Maternal Risk Factors in Hessen, Germany. (October 2012) Authors: Faas, D; Vajz, M; Hennewig, U; Misselwitz, B; Oehmke, F; Heckmann, M Journal: Archives of disease in childhood Issue: Volume 97(2012)Supplement 2 Page Start: A282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP021 Immunosuppressive and anti-TNF treatment is associated with a lower risk of migration from B1-to-B3-stage in Crohn's disease: 10-year follow-up data from the Swiss IBD cohort study. (16th January 2018) Authors: Cernoch, P; Fournier, N; Scharl, M; Zeitz, J; Morell, B; Greuter, T; Schreiner, P; Misselwitz, B; Safroneeva, E; Schoepfer, A; Vavricka, S R; Rogler, G; Biedermann, L Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Investigating the variations in survival rates for very preterm infants in 10 European regions: the MOSAIC birth cohort. Issue 3 (19th September 2008) Authors: Draper, E S; Zeitlin, J; Fenton, A C; Weber, T; Gerrits, J; Martens, G; Misselwitz, B; Breart, G Other Names: simple. Journal: Archives of disease in childhood Issue: Volume 94:Issue 3(2009) Page Start: F158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP037 Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study. (16th January 2018) Authors: Greuther, T; Scharl, S; Barthel, C; Rossel, J -B; Biedermann, L; Misselwitz, B; Vavricka, S; Rogler, G; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP06 Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression. (25th January 2019) Authors: Humbel, F; Juillerat, P; Scharl, M; Misselwitz, B; Schreiner, P; Macpherson, A; Rogler, G; von Känel, R; Yilmaz, B; Biedermann, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-148High rates of hepatocellular carcinoma within two years of starting treatment for chronic hepatitis C with direct antiviral agents but not with PEG-interferon/ Ribavirin (HORRID Study). (2nd July 2019) Authors: Karbeyaz, F; Müllhaupt, B; Winder, T; Misselwitz, B; Mertens, J; Siebenhuener, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P200 7α-Hydroxy-4-cholesten-3-one for diagnosis and management of bile acid malabsorption in IBD patients: 2-year clinical experience. (25th January 2019) Authors: Friedli, B; Prost, J-C; Brunner, F; Misselwitz, B; Wiest, R; Macpherson, A; Juillerat, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P337 Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patients. (16th January 2018) Authors: Wüstholz, F; Fournier, N; Greuter, T; Schreiner, P; Misselwitz, B; Zeitz, J; Scharl, M; Frei, P; Safroneeva, E; Schoepfer, A; Kaelin, M; Rogler, G; Vavricka, S R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P350 Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland. (25th January 2019) Authors: Perrig, K; Rossel, J-B; Biedermann, L; Schreiner, P; Roth, R; Zeitz, J; Greuter, T; Vavricka, S; Krupka, N; Juillerat, P; Rogler, G; Misselwitz, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P414 Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacity. (21st January 2022) Authors: Bianchi, R; Von Känel, R; Roth, R; Schreiner, P; Rossel, J B; Barry, M P; Dora, B; Kloth, P; Juillerat, P; Greuter, T; Misselwitz, B; Schoepfer, A; Scharl, M; Rogler, G; Biedermann, L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗